Animalcare Group (ANCR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

216.00p
   
  • Change Today:
    -4.00p
  • 52 Week High: 284.00
  • 52 Week Low: 208.00
  • Currency: UK Pounds
  • Shares Issued: 68.98m
  • Volume: 43,962
  • Market Cap: £149.01m
  • Beta: 0.02

ANCR Overview

Animalcare Group plc is an international veterinary pharmaceutical and services business driven by a collective belief that healthy animals can have a hugely beneficial effect on their owners and society. Listed on the UK’s AIM exchange, we have a direct commercial presence in seven European countries and export to more than 40 markets in Europe and beyond. We are focused on growing our business sustainably by bringing new and innovative animal health products to market through our own development pipeline, partnerships and via acquisition.

Key Personnel

CEO: Jenny Winter
CFO: Chris Brewster
Independent Non-Executive Director: Sylvia Metayer
Independent Non-Executive Director: Douglas Hutchens
Non-Executive Chairman: Jan Boone
Senior Independent Non-Executive Director: Edwin (Ed) Torr
Non-Executive Dir: Marc Coucke, Els Degroote

Contact Details

Address: Animalcare, Moorside, Monks Cross, York, United Kingdom, YO32 9LB
Phone: +44 (0) 1904 487687
Fax: +44 (0) 1904 487611
Website: http://www.animalcaregroup.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB0032350695

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

ANCR Market Data

Currency UK Pounds
Share Price 216.00p
Change Today -4.00p
% Change -1.82 %
52 Week High 284.00
52 Week Low 208.00
Volume 43,962
Shares Issued 68.98m
Market Cap £149.01m
Beta 0.02

ANCR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
1.98% above the market average1.98% above the market average1.98% above the market average1.98% above the market average1.98% above the market average
70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average70.83% above the sector average
Price Trend
46.44% above the market average46.44% above the market average46.44% above the market average46.44% above the market average46.44% above the market average
59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average59.18% above the sector average
Income
47.63% below the market average47.63% below the market average47.63% below the market average47.63% below the market average47.63% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
6.07% below the market average6.07% below the market average6.07% below the market average6.07% below the market average6.07% below the market average
9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average9.68% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

ANCR Dividends

  Latest Previous
  Interim Final
Ex-Div 17-Oct-24 20-Jun-24
Paid 15-Nov-24 19-Jul-24
Amount 2.00p 3.00p

Trades for 01-Apr-2025

Time Volume / Share Price
16:24 8,000 @ 214.30p
16:24 8,000 @ 214.00p
15:18 8,150 @ 214.80p
15:23 384 @ 214.82p
15:17 1,116 @ 216.00p

ANCR Key Personnel

CFO Chris Brewster
CEO Jenny Winter

Top of Page